Renaissance Capital logo

US IPO Week Ahead: Year's largest US tech company to IPO, Nutanix, leads 5-deal week

September 23, 2016
Week Ahead

Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the massive backlog of Silicon Valley tech IPOs with private valuations of more than $1 billion. The other three notable IPOs this week offer various growth plays in the health care space, including a medical REIT, genetic test company and a provider of health support services.

Renaissance Capital's IPO Calendar - Week of 9/26/2016
Issuer
Business
Symbol
Exchange
Deal Size
$mil
Price Range
Shares Filed
Lead Managers
MedEquities Realty Trust
Nashville, TN
MRT
NYSE
$259 $12 - $14
19,925,333
FBR Capital Markets
J.P. Morgan
  Recently-formed REIT focused on health care properties in Texas and California.
Nutanix
San Jose, CA
NTNX
Nasdaq
$168 $11 - $13
14,000,000
Goldman Sachs
Morgan Stanley
  Leading provider of hyperconverged IT infrastructure software and appliances.
Tabula Rasa HealthCare
Moorestown, NJ
TRHC
Nasdaq
$60 $13 - $15
4,300,000
Wells Fargo Securities
UBS Investment Bank
  Provides risk management solutions to reduce adverse drug events (ADEs) at long-term care facilities.
Fulgent Genetics
Temple City, CA
FLGT
Nasdaq
$60 $12 - $14
4,600,000
Credit Suisse
Piper Jaffray
  Offers genetic testing for over 7,500 conditions.
Full Spectrum
Sunnyvale, CA
FMAX
Nasdaq
$15 $7 - $9
1,875,000
Joseph Gunnar & Co.
  Develops and sells products used to create private cellular networks.

Find out why institutional investors rely on Renaissance Capital's Pre-IPO Research for these IPOs.
Follow us on Twitter (@IPOtweet) for IPO news as it happens and register for our updates on the IPO market.


Nutanix (NTNX): On file since December 2015, Nutanix plans to raise $168 million at a $2 billion market cap in its long-awaited IPO. Nutanix is a leader in the rapidly-growing market for "hyperconverged" networking, and it will be the year's second VC-backed tech "unicorn" after Twilio (TWLO; +327%). Few IPOs can claim over $200 million in billings in the most recent quarter with 118% growth, though its accumulated deficit of $442 million is just as rare. Recently, IPO investors have been favorable toward high-loss, high-growth stories, and Nutanix has already posted three consecutive quarters of positive cash flow from operations.

MedEquities Realty Trust (MRT): The week's largest IPO, MedEquities plans to raise $259 million at a market cap of nearly $400 million. While the REIT is concentrated both by geography (TX and CA are 86% of rent) and customers (top 5 are 97%), it boasts an experienced management team, a portfolio of long-term triple-net leases and a 6.5% annualized yield. Close peer Community Healthcare Trust (CHCT; 2015 IPO) is up 25% this year, while Global Medical REIT (GMRE) has traded up 4% from its June 2016 IPO.

Fulgent Genetics (FLGT): This small but fast-growing genetic test company is set to raise $60 million at a market cap of $235 million. Differentiated with its ability to more than 18,000 gene tests, Fulgent grew sales by 82% in the 2Q, reaching almost $4 million with a 24% operating margin. The seven diagnostics IPOs since 2015 average a return of -37%, though Fulgent's closest peers have outperformed in recent months.

Tabula Rasa HealthCare (TRHC): Hoping to raise $60 million at a market cap of $251 million, Tabula Rasa helps long-term care facilities avoid adverse drug events from mismanaged prescriptions. The company grew 32% in the first half of 2016, giving it trailing annual sales of $80 million with an adjusted EBITDA margin of 13%.

Full Spectrum (FMAX): This micro-cap company, which sells products for private cellular networks, pushed back its $15 million IPO to the week ahead. AzurRx BioPharma (AZRX), a biotech that originally set terms in August, still hopes to raise $12 million

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is up 2% year-to-date, while the S&P 500 is up 6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Alibaba (BABA) and Citizens Financial Group (CFG). The Renaissance International IPO Index is flat year-to-date, compared to +5% for ACWX. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Recruit Holdings and Aena S.A. To find out if this is the best ETF for you, visit our IPO Investing page.